Abstract:In China, recent years have witnessed significant growth in the pharmaceutical industry and an acceleration in pharmaceutical innovation. As a knowledge-intensive sector, the growth of the pharmaceutical industry in China marks an increasing need for protecting the enormous amounts of money invested in research and development. Arguably, the most efficient way for industry actors to recover their investments is through granting a limited duration of exclusive IP rights for the use and production of their products. Against this backdrop, over the past decades, China has adopted a series of IP-related laws and regulatory policies in China. On this basis, corporate demands and legislative efforts in China have led us to believe that a sound IP system that is compatible with China's development needs would necessarily help stimulate investment, facilitate technology transfer, and more importantly, allocate the rights and benefits over knowledge and resources among various stakeholders. This is because, at first sight, the IP rights approach contains an obvious solution to the problem of misappropriation or free riding by addressing the problem of non-excludability of traditional medical knowledge (TMK) and associated genetic resources. However, the real picture couldn't be more complex and different. The analysis of this article finds that China's existing IP systems supply a conducive context for pharmaceutical corporations to exploit the system's full strategic potential in plundering TMK and associated genetic resources. This situation has placed local communities and other TMK holders in China at a disadvantage.

The Protection of Intellectual Property Rights: the Core Strategy for Global Development of Traditional Chinese Medical Industry in the 21st Century

The Analysis of Intellectual Property Strategy Based on Current Capacity in China

Research on the Protection Strategy of the Traditional Chinese Medicine Intellectual Property

On the Construction of SMEs Intellectual Property Protection Ability

Research on the Path to Breakthrough in the Dilemma of Chinese Traditional Medicine Intellectual Property Protection

Intellectual Property Tools in Safeguarding Intangible Cultural Heritage: A Chinese Perspective

Analysis on Situation of Traditional Chinese Medicine Development and Protection Strategies in China

The International Protection of Intellectual Property Rights and the Challenges China is Confronted With

A Development Opportunity and Strategic Thinking for the Comprehensive Healthcare Industry of Traditional Chinese Medicine

Development Strategy of Traditional Chinese Medicine in the New Era

Pharmaceutical corporate power, traditional medical knowledge, and intellectual property governance in China

Protecting traditional knowledge of Chinese medicine: concepts and proposals

Civil Right Socialization for the Legislation Value Tropism of Intellectual Property

Understanding the protecting intellectual property right in the laboratories of the Chinese researching and opening Universities

Intellectual Property Protection And Firm Strategy In The China Integrated Circuit Industry

On Protection of Intangible Cultural Heritage in China from the Intellectual Property Rights Perspective

Research on Intellectual Property Right Protection of Genetic Resources in China Under Benefit-Sharing

Information,Intellectual Property and China's Strategy of Intellectual Property

Analysis of Protecting for Chinese Medical and Pharmaceutical Intellectual Property

Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions

Analysis on the Promotion of Patent Conversion Strategy of Traditional Chinese Medicine